Loading...
Search for:
cancer-vaccine
0.004 seconds
Prediction of HLA-Peptide Binding using 3D Structural Features
, M.Sc. Thesis Sharif University of Technology ; Sharifi Zarchi, Ali (Supervisor)
Abstract
The human leukocyte antigen protein, commonly known as HLA, has the ability to present small protein fragments called peptides on the surface of cells, whether they originate from within the cell or externally. The binding of these peptides to HLA receptors is a crucial step that triggers an immune response. By estimating the affinity between peptides and HLA class I, we can identify novel antigens that have the potential to be targeted by cancer therapeutic vaccines. Computational methods that predict the binding affinity between peptides and HLA receptors have the potential to expedite the design process of cancer vaccines. Currently, most computational methods exclusively rely on...
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
, Article Cancer Cell International ; Volume 20, Issue 1 , September , 2020 ; Tafsiri, E ; Cho, W. C. S ; Ghaemi, A ; Sharif University of Technology
BioMed Central Ltd
2020
Abstract
Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients, a so called "adoptive cell transfer", or ACT, process. Construction of allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted T-cells and prepare them to specifically act against tumor cells with enhanced function and durability and least side-effects. In this context, CRISPR technology can be used to produce universal T-cells, equipped with recombinant T cell...